NLRP3 and Anxiety: Other works have also shown that treatments such as sodium butyrate and ultramicronized palmitoylethanolamide can reduce PTX-induced depressive- and anxiety-like behaviors through inhibiting the expression of several NLRP3-derived proinflammatory cytokines in the brain [48,49].